Search

Europe’s bid to lead the world in developing hydrogen and fuel cells risks failure because the planned investment is too little, the trade group Fuel Cell Europe heard.

Global research spending soared in 2007, with Microsoft pulling into the lead. But don’t expect a repeat this year, warns Commissioner Potočnik.

The credit crunch is strangling biotech. And with no access to capital, the only way out is to sell to big pharma.

Who can deliver on science and innovation? I can, says the UK’s new Science Minister, Paul Drayson.

As stock markets turn their backs on the high-risk sectors, France Biotech’s annual survey reveals the depths to which investment has fallen.